BG105866A - Heteroaryl amidines, methylamidines and guanidines as protease inhibitors - Google Patents
Heteroaryl amidines, methylamidines and guanidines as protease inhibitorsInfo
- Publication number
- BG105866A BG105866A BG105866A BG10586601A BG105866A BG 105866 A BG105866 A BG 105866A BG 105866 A BG105866 A BG 105866A BG 10586601 A BG10586601 A BG 10586601A BG 105866 A BG105866 A BG 105866A
- Authority
- BG
- Bulgaria
- Prior art keywords
- compounds
- methylamidines
- guanidines
- protease inhibitors
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24706299A | 1999-02-09 | 1999-02-09 | |
PCT/US1999/018065 WO2000047578A1 (en) | 1999-02-09 | 1999-08-11 | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BG105866A true BG105866A (en) | 2002-06-28 |
Family
ID=22933398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105866A BG105866A (en) | 1999-02-09 | 2001-09-01 | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1150979A1 (hu) |
JP (1) | JP2002536446A (hu) |
KR (1) | KR20010098982A (hu) |
CN (1) | CN1337961A (hu) |
AU (1) | AU5671799A (hu) |
BG (1) | BG105866A (hu) |
BR (1) | BR9917036A (hu) |
CA (1) | CA2362390A1 (hu) |
CZ (1) | CZ20012858A3 (hu) |
EA (1) | EA200100882A1 (hu) |
HU (1) | HUP0201475A2 (hu) |
IL (1) | IL144560A0 (hu) |
MX (1) | MXPA01008084A (hu) |
NO (1) | NO324887B1 (hu) |
NZ (1) | NZ513701A (hu) |
PL (1) | PL351767A1 (hu) |
SK (1) | SK11422001A3 (hu) |
WO (1) | WO2000047578A1 (hu) |
ZA (1) | ZA200106849B (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000047194A2 (en) * | 1999-02-09 | 2000-08-17 | 3-Dimensional Pharmaceuticals, Inc. | METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
BR0311419A (pt) * | 2002-05-28 | 2005-04-05 | Dimensional Pharm Inc | Amidinas de tiofeno suas composições e métodos de tratamento de doenças e condições mediadas por complemento |
AU2003302238A1 (en) | 2002-12-03 | 2004-06-23 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
US7482376B2 (en) * | 2003-07-03 | 2009-01-27 | 3-Dimensional Pharmaceuticals, Inc. | Conjugated complement cascade inhibitors |
JP2007523868A (ja) * | 2003-07-10 | 2007-08-23 | アキリオン ファーマシューティカルズ,インコーポレーテッド | ウイルス複製の阻害薬として有用な置換アリールチオウレア誘導体類 |
CA2555959A1 (en) | 2004-02-12 | 2005-09-01 | Molecular Insight Pharmaceuticals | Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
US8841305B2 (en) | 2008-10-09 | 2014-09-23 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Activators of the human pyruvate kinase M2 receptor |
WO2011005660A1 (en) | 2009-07-08 | 2011-01-13 | Valocor Therapeutics, Inc. | Tofa analogs useful in treating dermatological disorders or conditions |
EP2563761A1 (en) | 2010-04-29 | 2013-03-06 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Activators of human pyruvate kinase |
US8691184B2 (en) * | 2011-01-25 | 2014-04-08 | The Regents Of The University Of Michigan | Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same |
AR086744A1 (es) * | 2011-06-28 | 2014-01-22 | Nippon Soda Co | Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria |
EP2606726A1 (de) * | 2011-12-21 | 2013-06-26 | Bayer CropScience AG | N-Arylamidine-substituierte trifluoroethylsulfid-Derivate als Akarizide und Insektizide |
TWI644899B (zh) | 2013-02-04 | 2018-12-21 | 健生藥品公司 | Flap調節劑 |
EP3495359A1 (en) | 2013-02-04 | 2019-06-12 | Janssen Pharmaceutica NV | Flap modulators |
BR112020019804A2 (pt) * | 2018-03-30 | 2021-01-05 | Sumitomo Chemical Company, Limited | Composto heterocíclico e composição de controle de peste artrópode contendo o mesmo |
CN109020837A (zh) * | 2018-07-27 | 2018-12-18 | 广东省石油与精细化工研究院 | 一种2-取代苯基-乙脒盐酸盐的制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4220654A (en) * | 1979-06-04 | 1980-09-02 | Merck & Co., Inc. | Cyclic imidazole cyanoguanidines |
US4424367A (en) * | 1982-08-19 | 1984-01-03 | Norwich Eaton Pharmaceuticals, Inc. | 5-(4-Aminophenyl)-2-thiophenecarboximidamide hydrochloride hemihydrate |
JPS59139357A (ja) * | 1983-01-28 | 1984-08-10 | Torii Yakuhin Kk | アミジン誘導体 |
DE3427865A1 (de) * | 1984-07-27 | 1986-02-06 | Torii & Co., Tokio/Tokyo | Amidinoverbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
US5340833A (en) * | 1992-05-01 | 1994-08-23 | Eisai Co., Ltd. | Urokinase inhibitors |
GB9312761D0 (en) * | 1993-06-21 | 1993-08-04 | Wellcome Found | Amino acid derivatives |
CA2170735A1 (en) * | 1993-10-21 | 1995-04-27 | Foe S. Tjoeng | Amidino derivatives useful as nitric oxide synthase inhibitors |
ZA951617B (en) * | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
TW414795B (en) * | 1996-07-01 | 2000-12-11 | Yamanouchi Pharma Co Ltd | A thiophene derivative and the pharmaceutical composition |
DE19632773A1 (de) * | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
PE121699A1 (es) * | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
EP1051431A1 (de) * | 1998-01-26 | 2000-11-15 | Basf Aktiengesellschaft | Thrombininhibitoren |
EP1049673A1 (de) * | 1998-01-26 | 2000-11-08 | Basf Aktiengesellschaft | Heterocyclische amidine als kallikrein protease inhibitoren |
ATE223408T1 (de) * | 1998-02-09 | 2002-09-15 | Dimensional Pharm Inc | Heteroaryl-amidinen,-methylamidinen und - guanidinen als protease inhibitoren, insbesondere als urokinase inhibitoren |
EP1068190A1 (en) * | 1998-03-31 | 2001-01-17 | Warner-Lambert Company Llc | Quinoxalinones as serine protease inhibitors such as factor xa and thrombin |
KR20010042296A (ko) * | 1998-03-31 | 2001-05-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 세린 프로테아제 억제제로서의 벤즈옥사지논/벤조티아지논 |
CA2312953A1 (en) * | 1998-03-31 | 1999-10-07 | Warner-Lambert Company | Quinolones as serine protease inhibitors |
-
1999
- 1999-08-11 CZ CZ20012858A patent/CZ20012858A3/cs unknown
- 1999-08-11 MX MXPA01008084A patent/MXPA01008084A/es unknown
- 1999-08-11 IL IL14456099A patent/IL144560A0/xx unknown
- 1999-08-11 CN CN99816415A patent/CN1337961A/zh active Pending
- 1999-08-11 SK SK1142-2001A patent/SK11422001A3/sk unknown
- 1999-08-11 WO PCT/US1999/018065 patent/WO2000047578A1/en not_active Application Discontinuation
- 1999-08-11 CA CA002362390A patent/CA2362390A1/en not_active Abandoned
- 1999-08-11 AU AU56717/99A patent/AU5671799A/en not_active Abandoned
- 1999-08-11 JP JP2000598498A patent/JP2002536446A/ja active Pending
- 1999-08-11 EA EA200100882A patent/EA200100882A1/ru unknown
- 1999-08-11 EP EP99943667A patent/EP1150979A1/en not_active Withdrawn
- 1999-08-11 HU HU0201475A patent/HUP0201475A2/hu unknown
- 1999-08-11 NZ NZ513701A patent/NZ513701A/xx not_active Application Discontinuation
- 1999-08-11 KR KR1020017010094A patent/KR20010098982A/ko not_active Application Discontinuation
- 1999-08-11 BR BR9917036-1A patent/BR9917036A/pt not_active IP Right Cessation
- 1999-08-11 PL PL99351767A patent/PL351767A1/xx not_active Application Discontinuation
-
2001
- 2001-08-07 NO NO20013853A patent/NO324887B1/no not_active IP Right Cessation
- 2001-08-20 ZA ZA200106849A patent/ZA200106849B/en unknown
- 2001-09-01 BG BG105866A patent/BG105866A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR9917036A (pt) | 2002-07-30 |
SK11422001A3 (sk) | 2002-04-04 |
NO324887B1 (no) | 2007-12-27 |
WO2000047578A1 (en) | 2000-08-17 |
MXPA01008084A (es) | 2004-09-10 |
AU5671799A (en) | 2000-08-29 |
EA200100882A1 (ru) | 2002-04-25 |
JP2002536446A (ja) | 2002-10-29 |
CZ20012858A3 (cs) | 2002-05-15 |
ZA200106849B (en) | 2002-11-20 |
KR20010098982A (ko) | 2001-11-08 |
NO20013853L (no) | 2001-10-09 |
EP1150979A1 (en) | 2001-11-07 |
CA2362390A1 (en) | 2000-08-17 |
NZ513701A (en) | 2001-09-28 |
CN1337961A (zh) | 2002-02-27 |
IL144560A0 (en) | 2002-05-23 |
NO20013853D0 (no) | 2001-08-07 |
HUP0201475A2 (hu) | 2003-10-28 |
PL351767A1 (en) | 2003-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69902754D1 (de) | Heteroaryl-amidinen,-methylamidinen und -guanidinen als protease inhibitoren, insbesondere als urokinase inhibitoren | |
BG105866A (en) | Heteroaryl amidines, methylamidines and guanidines as protease inhibitors | |
GEP20074098B (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
WO2000035886A3 (en) | (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors | |
WO2004041776A3 (en) | SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS | |
CA2379747A1 (en) | Novel succinate derivative compounds useful as cysteine protease inhibitors | |
YU17003A (sh) | Spiroheterociklični nitrili upotrebljivi kao reverzibilni inhibitori cisteinskih proteaza | |
WO2002042273A3 (en) | Acid derivatives useful as serine protease inhibitors | |
HUP0203130A2 (hu) | Hexahidrofuro[2,3-b]furán-3-il-N-{3-(1,3-benzodioxol-5-il-szulfonil)-(izobutil)-amino-1-benzil-2-(hidroxi-propil)}-karbamát mint retrovírus-proteáz-gátló | |
MXPA03011907A (es) | Fluoropirrolidinas como inhibidores de dipeptidil peptidasa. | |
WO2004083174A3 (en) | Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors | |
HK1045502A1 (en) | Nitrogen containing heterobicycles as factor xa inhibitors. | |
MY129188A (en) | Metalloproteinase inhibitors | |
NZ333394A (en) | Amidino derivatives and their use as thrombin inhibitors | |
EP0906091A4 (en) | AMIDINOHYDRAZONES USED AS PROTEASE INHIBITORS | |
WO2004031145A3 (en) | Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors | |
MXPA03005254A (es) | Inhibidores de serina proteasa. | |
ATE260112T1 (de) | Amidino proteaseinhibitoren | |
HK1029936A1 (en) | Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors | |
WO2002080853A3 (en) | Fused heterocyclic inhibitors of factor xa | |
MXPA98002443A (es) | Inhibidores de guanidino proteasas. | |
WO2005048922A3 (en) | Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors | |
IL154077A0 (en) | New amidino derivatives and their use as thrombin inhibitors | |
MY132033A (en) | New mandelic acid derivatives and their use as thrombin inhibitors | |
BG105985A (en) | Prodrugs of thrombin inhibitors |